Albert N. Marchio II, the Interim Chief Financial Officer of NexImmune, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated April 5, 2024, indicates that Marchio does not beneficially own any securities in the company. The filing, which was signed by attorney-in-fact Jeffrey Cohan on behalf of Marchio on April 10, 2024, is a standard procedure for individuals in key positions within publicly traded companies, as mandated by the Securities Exchange Act of 1934. This filing helps maintain transparency in the market by disclosing the ownership stakes of senior executives and directors.

Albert N. Marchio II, the Interim Chief Financial Officer of NexImmune, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated April 5, 2024, indicates that Marchio does not beneficially own any securities in the company. The filing, which was signed by attorney-in-fact Jeffrey Cohan on behalf of Marchio on April 10, 2024, is a standard procedure for individuals in key positions within publicly traded companies, as mandated by the Securities Exchange Act of 1934. This filing helps maintain transparency in the market by disclosing the ownership stakes of senior executives and directors.